  | Joannes, L., Dupont, L., Stock, L., Arpigny, E., Hubert, P., Ancion, M., Luyckx, M., Abinet, J., Peng, W., Calaldo, D., Noël, A., Marichal, T., Herfs, M., Deroanne, C., & Colige, A. (23 June 2025). The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system. Cancer Cell International, 25 (1), 229. doi:10.1186/s12935-025-03880-1  Peer Reviewed verified by ORBi |
 | Joannes, L. (2025). Antagonistic roles of ADAMTS2 in cancer progression: inhibiting primary tumor growth while being essential for metastatic spread [Doctoral thesis, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/327255 |
 | Dupont, L.* , Noël, A.* , Colige, A.* , Joannes, L. (Other coll.), Morfoisse, F. (Other coll.), BLACHER, S. (Other coll.), Monseur, C. (Other coll.), & Deroanne, C. (Other coll.). (2022). ADAMTS2 and ADAMTS14 substitute ADAMTS3 in adults for proVEGFC activation and lymphatic homeostasis. JCI Insight. doi:10.1172/jci.insight.151509 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Leduc, C., Dupont, L., Joannes, L., Monseur, C., Baiwir, D., Mazzucchelli, G., Deroanne, C., Colige, A.* , & Bekhouche, M.*. (2021). In vivo N-Terminomics Highlights Novel Functions of ADAMTS2 and ADAMTS14 in Skin Collagen Matrix Building. Frontiers in Molecular Biosciences. doi:10.3389/fmolb.2021.643178 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
